Bacampicillin

Bacampicillin (INN) is a penicillin antibiotic. It serves as a prodrug designed to improve the oral bioavailability of ampicillin.
History and Development[edit]
Bacampicillin was developed to enhance the absorption of ampicillin in the body. As a prodrug, bacampicillin is metabolized in the body to produce ampicillin, thereby allowing for greater concentrations of the antibiotic in the bloodstream when taken orally.
Brand Names and Availability[edit]
Bacampicillin is marketed under the following brand names:
- Spectrobid – Manufactured by Pfizer
- Penglobe – Produced by AstraZeneca
Despite its usage in various regions, bacampicillin is not available in the United States.
Mechanism of Action[edit]
Like ampicillin, bacampicillin functions by inhibiting the synthesis of the bacterial cell wall, leading to the death of susceptible bacteria. The primary advantage of bacampicillin over ampicillin is its improved bioavailability when taken orally, ensuring more consistent therapeutic levels in the body.
Indications[edit]
Bacampicillin is prescribed for the treatment of various bacterial infections, especially those caused by penicillin-sensitive organisms. Its efficacy and indications largely align with those of ampicillin due to its conversion to ampicillin in vivo.
Side Effects and Precautions[edit]
Patients using bacampicillin may experience side effects common to penicillin antibiotics, such as gastrointestinal disturbances, allergic reactions, and skin rashes. It is essential to avoid use in patients with known penicillin allergies.
References[edit]
- Johnson, L.R. (2015). Antibiotics and Their Applications. Oxford University Press.
- Smith, A. & Green, B. (2013). Modern Developments in Antibacterial Therapy. Elsevier.
Penicillin antibiotics[edit]
- penicillins first generation (natural penicillins)
- penicillins second generation (penicillinase-resistant penicillins)
- penicillins third generation (aminopenicillins)
- see also amoxicillin-clavulanate
- penicillins fourth generation (extended-spectrum penicillins)
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian